Company Filing History:
Years Active: 1987
Title: Innovator Spotlight: Kohya Shiratori and His Contribution to Anti-inflammatory Medications
Introduction: Kohya Shiratori, an accomplished inventor based in Yokohama, Japan, has made significant strides in the field of medicinal chemistry. With a notable patent to his name, Shiratori's work focuses on developing novel compounds with potential therapeutic applications in anti-inflammatory and analgesic treatments.
Latest Patents: Kohya Shiratori holds a patent for anthranilic acid ester derivatives, which possess remarkable anti-inflammatory and analgesic effects. The patent describes these derivatives characterized by the general formula (I), where R represents an alkyl group containing 1 to 3 carbon atoms substituted with either a pyridyl group or a furanmethyl group. The unique properties of these compounds enable them to penetrate the skin effectively, making them suitable candidates for use as anti-inflammatory and analgesic agents.
Career Highlights: Currently, Kohya Shiratori is associated with Shiseido Company, Limited, a leading global player in the cosmetics and skincare industry. His innovative contributions are well-recognized within the company and the broader pharmaceutical community, particularly for their potential implications in improving patient care through enhanced topical formulations.
Collaborations: Throughout his career, Shiratori has collaborated with esteemed colleagues such as Yoshihisa Sato and Tetsuji Hirao. These collaborations have fostered a rich exchange of ideas and expertise, contributing to the advancement of research in medicinal compounds and applications in the healthcare sector.
Conclusion: Kohya Shiratori's contributions to the field of anti-inflammatory medication through his innovative patent on anthranilic acid ester derivatives underscore his role as a key inventor in the pharmaceutical landscape. His ongoing work at Shiseido Company, Limited, along with valuable collaborations, promises to lead to further advancements that may significantly benefit the medical community and patients in need of effective therapeutic solutions.